Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Phase of Trial: Phase II
Latest Information Update: 11 Aug 2009
At a glance
- Drugs Antithrombin III (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- 11 Aug 2009 New trial record